Global Health Limited, which operates the Medanta hospital network across North and East India, on Tuesday reported a 19.1 per cent year-on-year rise in consolidated total income to ₹11,428 million for the quarter ended December 31, 2025 (Q3 FY26), driven by strong patient volumes and improved realizations. EBITDA excluding the newly commissioned Noida hospital rose 10.9 per cent year-on-year to ₹2,814 million, with margins of 25.4 per cent. However, consolidated EBITDA including Noida declined 1.7 per cent to ₹2,494 million, reflecting initial operating losses at the new facility. Medanta Noida, which began operations in September 2025, reported revenue of ₹343 million and an EBITDA loss of ₹320 million during the quarter.
Profit after tax stood at ₹950 million in Q3 FY26, impacted by depreciation and finance costs related to the Noida hospital, as well as a one-time exceptional expense of ₹366 million arising from the statutory implementation of new Labour Codes.
During the quarter, the company added 144 beds—42 in Patna and 102 in Noida—while inpatient and outpatient volumes grew 14.3 per cent and 19.5 per cent, respectively. International patient revenue surged 29.9 per cent to ₹703 million. For the first nine months of FY26, total income increased 17.6 per cent to ₹33,131 million, with PAT rising 8.5 per cent to ₹4,124 million, despite losses at the Noida facility.